Launched by Cosmeditech in the UK earlier this year, TargetCool is a first-of-its-kind FDA and CE-approved technology that can be used to deliver skin treatments such as skinboosters, exosomes and other cosmeceuticals beneath the surface of the skin using a supersonic CO2 jet (up to 100m/s).
Using ground-breaking technology, including compressed CO2 cryogen (modulated by digital controls), IR sensors and a calibrated nozzle, TargetCool delivers precise, controlled and rapid cooling to the skin.
TargetCool can also be combined with shallow microneedling at a depth of 0.4mm. This is to open active channels on the epidermis so that a healthcare practitioner can subsequently use TargetCool in boosting mode to deliver medical-grade infusions such as hyaluronic acid serums, skinboosters and mesotherapy cocktails. TargetCool can also be used to deliver exosomes, which is the latest medical innovation for skin rejuvenation, following either microneedling, RF-needling or laser. Each boosting container can be filled with up to 3ml of the desired solution. There is no downtime for patients – in fact, the CO2 cooling helps to constrict blood vessels, improving circulation and oxygenation to the skin for improved healing times and quicker recovery.
This study compares the penetration of hyaluronic acid using fluorescence transillumination imaging results from ex vivo human-derived skin. The study evaluates three methods: topical application, TargetCool boosting mode post microneedling, and TargetCool boosting mode alone.
The imaging results demonstrate that TargetCool boosting mode alone is capable of delivering hyaluronic acid into the dermis with an increased penetration of 165%. Quantitative analysis of fluorescence intensities reveals a 215% increased rate of penetration if TargetCool is used in conjunction with micro-needling, compared to the topical application group. These findings further underscore the efficacy of TargetCool boosting mode in delivering hyaluronic acid into the dermis.
TargetCool also has the ability to numb targeted areas prior to injections, ensuring a virtually pain-free experience for patients undergoing non-surgical treatments. This feature ensures patients are as comfortable as possible during non-surgical aesthetic procedures. Cosmeditech research shows that 93% of patients tested preferred TargetCool to lidocaine for lip filler treatments, and 78% of patients prefer TargetCool to lidocaine for general filler treatments. Without the need for lidocaine, waiting times can be kept to a minimum, enabling Healthcare Practitioners to treat more patients in a day.
TargetCool in cooling mode can be used alongside lip fillers, general fillers, mesotherapy, toxin treatments, PRP therapy, subcutaneous injections and intramuscular injections.
TargetCool offers improved safety for injectables by helping prevent complications and damage to tissues. A consistent temperature is maintained throughout the treatment, which is repeatable with standardising treatment protocols.
The carbon rejuvenation delivered by TargetCool provides superior outcomes by reducing inflammation, increasing oxygen supply to tissues and increasing blood flow in the treated areas.
The practitioner can also use TargetCool for precision cryotherapy, utilising its freezing nozzle, which uses liquid CO2 at -79degrees celcius, enabling the removal of skin tags, warts, verrucae and other skin lesions.
TargetCool is innovative because it combines all three modes (cooling for pain management, boosting and freezing) into one streamlined, ergonomic, easy-to-use device.
There is a one-off fee for the device, but ongoing consumables are minimal (canisters and boosting containers) - with that comes in clinic support from Cosmeditech, training, marketing material and social media tools.
For further information, visit www.targetcool.co.uk or email info@cosmeditech.com to book a demonstration in your clinic.